20,175 followers
Preferences for Funding New High-Cost Cancer Drugs: A Critical Review of the Evidence from Patients, Public & Payers https://t.co/VAmfIituha
Preferences for Funding New High-Cost Cancer Drugs: A Critical Review of the Evidence from Patients, Public & Payers https://t.co/VAmfIituha